As of 21 Sept 2026, Ishita Drugs & Industries Ltd share price is ₹71.00. The stock opened at ₹71.00 and had closed at ₹71.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹66.00 and a high of ₹90.85. In terms of performance, Ishita Drugs & Industries Ltd share price has decreased by 15.04% over the past six months and has decreased by 11.25% over the last year.
Ishita Drugs Stock Price Chart
Ishita Drugs & Industries Ltd Overview
About Ishita Drugs
Ishita Drugs & Industries is engaged in the business of manufacturing of various APIs (Active Pharma Ingredients) and drug intermediates. It has built up a reputation as a manufacturer of “high quality” products and is known for its ethical dealings in business. The company supplies its products to leading pharmaceutical companies of India. The products are also being exported to various countries across the world.
Ishita Drugs & Industries Ltd Historical Performance
Ishita Drugs & Industries Ltd Fundamentals
Ishita Drugs & Industries Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 15.13 | 15.34 | 15.47 | 12.27 | 14.20 |
| EBITDA | 1.24 | 1.34 | 1.19 | 0.96 | 1.19 |
| Net Profit | 0.78 | 0.87 | 0.75 | 0.58 | 0.81 |
| EPS | 2.60 | 2.90 | 2.50 | 1.93 | 2.69 |
Ishita Drugs & Industries Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 70.33 |
| Resistance 1 (R1) | 72.33 |
| Pivot Point | 71.67 |
Ishita Drugs & Industries Ltd Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Jagdish Agrawal | Managing Director |
| Abha Agrawal | Non Executive Director |
| Arvind Sapkal | Non Executive Independent Director |
Ishita Drugs & Industries Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,837.30-1.61% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹9,375.00+0.56% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,840.00-0.72% | ₹1,46,951.32 | 64.68 | 25.49% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Ishita Drugs & Industries Ltd today is ₹71.00 on NSE and ₹71.00 on BSE.
- The 52-week high of Ishita Drugs & Industries Ltd is ₹90.85, while the 52-week low is ₹66.00.
- The current market capitalisation of Ishita Drugs & Industries Ltd is approximately ₹21 crore.
- The P/E (Price-to-Earnings) ratio of Ishita Drugs & Industries Ltd is 30.08. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Ishita Drugs & Industries Ltd is 1.84. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Ishita Drugs & Industries Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for Ishita Drugs on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Ishita Drugs & Industries Ltd has delivered a return of approximately -14.04%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Ishita Drugs & Industries Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 50.04% promoters, 0.00% FIIs, 0.00% DIIs, and 47.89% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
